New Patent Signals Faster Disease Diagnostics

Accelr8 Technology has been awarded U.S. Patent 6,844,028 for its OptiChem surface chemistry, a new coating that makes it possible to selectively capture, target and analyze individual bacteria, thus setting a new standard in rapid bacterial pathogen analysis. OptiChem is a component of the company's new BACcelr8r diagnostic system that, when fully developed, has the potential to replace bacterial culturing by producing test results in a matter of hours.

Yahoo News (http://biz.yahoo.com/prnews/050202/law066_1.html)